MedPath

Effect of Shenfu Injection on Antishock and Postoperative Cognitive Impair in Patients with Hemorrhagic Shock

Phase 1
Recruiting
Conditions
postoperative outcomes
Registration Number
ITMCTR2100005196
Lead Sponsor
affiliated hospital of shandong university of traditional Chinese medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1, voluntary signed informed consent; 2, Age 18-80 years; 3, femoral Shaft Fracture Open Reduction Patients; 4, Combined spinal-epidural Anesthesia;

Exclusion Criteria

1. Severe Cardiopulmonary Dysfunction; 2. Disturbance of consciousness or poor compliance with the completion of the study; 3. ASA Level 4 or above; 4. The patient is participating in other clinical trials within 1 month.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
incidence of postoperative delirium;
Secondary Outcome Measures
NameTimeMethod
all cause mortality within 30 days;length of hospital stay;incidence of non-postoperative delirium;
© Copyright 2025. All Rights Reserved by MedPath